Case Study: Top-10 Global Pharmaceutical Company achieves early Japan FPI and 99.27% eCOA adherence with Medable

Medable beats forecasted FPI date while raising eCOA adherence in Japan

The Top-10 Global Pharmaceutical Company faced eCOA adherence and patient enrollment challenges for a pain-management clinical trial in Japan, where unique regulatory, cultural, and logistical factors risked delaying First Patient In (FPI). They partnered with Medable to provide a localized eCOA and trial support solution to improve site and patient experiences and keep the program on schedule.

Medable delivered a region-specific program — direct engagement with Japanese study teams, fully translated materials and training, local device procurement to meet giteki requirements, end-to-end testing, and tailored onboarding — ensuring all sites and CRAs were trained and devices arrived ahead of FPI. As a result, Medable achieved FPI ahead of schedule and drove 99.27% eCOA adherence, with strong site and patient feedback and the client calling Medable’s approach “the gold standard.”